Novartis Statement to the Cystinosis Community
October 24, 2024 Dear Cystinosis Community, We hope that you are enjoying the fall. The Novartis teams have been hard at work collaborating with the cystinosis community, cystinosis patient advocacy groups, cystinosis experts and health authorities to move the program forward since the Novartis acquisition of the investigational autologous hematopoietic stem cell (HSC) gene therapy […]
Novartis Statement to the Cystinosis Community Read More »
